Pathologic Response of Primary Rectal Cancer to Oxaliplatin-Based Chemotherapy

ABSTRACT

Management of stage IV rectal cancer is controversial, and different strategies may be useful. Preoperative chemotherapy for liver metastases might cause pathologic changes over the primary rectal tumor. In this study, the authors show the pathologic regression of the primary rectal tumor after neoadjuvant chemotherapy treatment. Patients suffering stage IV rectal cancer underwent surgery after oxaliplatin-based chemotherapy. Age, gender, type of surgery, carcinoembryogenic antigen (CEA) level, presence of metastatic disease in one or multiple organs, ypT, ypN, and circumferential resection margin (CRM) were evaluated. Pathologic response of the primary tumor was estimated by using three conventional grading systems and a semiquantitative system assessed by the amount of viable cells out of the total tumor area macroscopically described. Fibrosis, necrosis, and colloid response were evaluated with a semiquantitative system. A complete pathologic response (ypTO) was found in one patient. A good response was observed in the 41.6% of the cases with all grading systems. Presence of fibrosis in the primary tumor was found in six cases. No patient showed CRM involvement. One patient developed a local recurrence. Oxaliplatin-based chemotherapy for stage IV rectal cancer provides high rates of pathologic regression in the rectal tumor and may allow surgery without CRM involvement.

KEYWORDS

Rectal cancer - neoadjuvant radiotherapy - neoadjuvant chemotherapy - pathologic regression

REFERENCES

• 1 Nordlinger B, Sorbye H, Glimelius B EORTC Gastro-Intestinal Tract Cancer Group et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.  Lancet. 2008;  371 (9617) 1007-1016
• 2 Sigurdsson H K, Kørner H, Dahl O, Skarstein A, Søreide J A. Norwegian Rectal Cancer Group . Palliative surgery for rectal cancer in a national cohort.  Colorectal Dis. 2008;  10 (4) 336-343
• 3 Assumpcao L, Choti M, Gleizer A L et al.. Patterns of recurrence following liver resection for colorectal matastases: effect of primary rectal tumor site.  Arch Surg. 2008;  143 (8) 743-749
• 4 Mentha G, Majno P E, Andres A, Rubbia-Brandt L, Morel P, Roth A D. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary.  Br J Surg. 2006;  93 (7) 872-878
• 5 Valentini V, Coco C, Picciocchi A et al.. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients.  Int J Radiat Oncol Biol Phys. 2002;  53 (3) 664-674
• 6 Rödel C, Martus P, Papadoupolos T et al.. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.  J Clin Oncol. 2005;  23 (34) 8688-8696
• 7 Mandard A M, Dalibard F, Mandard J C et al.. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations.  Cancer. 1994;  73 (11) 2680-2686
• 8 Dworak O, Keilholz I, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy.  Int J Colorectal Dis. 1997;  12 (1) 19-23
• 9 Ryan R, Gibbons D, Hyland J M et al.. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer.  Histopathology. 2005;  47 (2) 141-146
• 10 Gervaz P, Rubbia-Brandt L, Andres A et al.. Neoadjuvant chemotherapy in patients with stage IV colorectal cancer: a comparison of histological response in liver metastases, primary tumors, and regional lymph nodes.  Ann Surg Oncol. 2010;  17 (10) 2714-2719
• 11 Suárez J, Vera R, Balén E et al.. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.  Colorectal Dis. 2008;  10 (6) 563-568
• 12 Dresen R C, Beets G L, Rutten H J et al.. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall?.  Radiology. 2009;  252 (1) 71-80
• 13 Morcos B, Baker B, Al Masri M, Haddad H, Hashem S. Lymph node yield in rectal cancer surgery: effect of preoperative chemoradiotherapy.  Eur J Surg Oncol. 2010;  36 (4) 345-349